Trials / Terminated
TerminatedNCT05082480
Evaluate the Effectiveness of Crosslinked HA on the Adhesion Preventing After Trigger Finger Release Surgery
A Prospective, Double-Centre, Randomized, Evaluator/Subject-blinded, Control Clinical Study: to Evaluate the Effectiveness of the Use of a Novel Crosslinking Hyaluronan Hydrogel on the Prevention of the Adhesion Occurrence After Trigger Finger Release Surgery
- Status
- Terminated
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 5 (actual)
- Sponsor
- SciVision Biotech Inc. · Industry
- Sex
- All
- Age
- 20 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
To Evaluate the Effectiveness of the use of a Novel Crosslinking Hyaluronan Hydrogel on the Prevention of the Adhesion Occurrence After Trigger Finger Release Surgery
Detailed description
The medical device is a bioabsorbable, extensible, crosslinked, 6% hyaluronic acid gel using fermentation sourced hyaluronic acid as a major component. This product could perfectly attach to the tissue surface, creating anti-adhesion layer which avoids post-surgical adhesion and is completely resorbed over time. This study is aimed to evaluate the effectiveness of the use of a novel crosslinking hyaluronan hydrogel on the prevention of the adhesion occurrence after trigger finger release surgery.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Hyaluronic acid (HA) | Hyaluronic acid (HA) |
| DEVICE | Saline | Saline |
Timeline
- Start date
- 2022-05-05
- Primary completion
- 2023-04-28
- Completion
- 2023-04-28
- First posted
- 2021-10-19
- Last updated
- 2023-05-12
Locations
2 sites across 1 country: Taiwan
Source: ClinicalTrials.gov record NCT05082480. Inclusion in this directory is not an endorsement.